Accelerating the discovery of a cure for ALS.

Scientific Advisors
Board of Directors
< Home


Ms. Amy Jenkins is Chief Operating Officer and Managing Partner at Education Elements, a company that partners with school districts to design and implement personalized learning.  She completed her MBA at Harvard Business School where she was awarded the Horace W. Goldsmith Award for outstanding commitment to the non-profit sector.  After business school, Amy spent a fellowship year at NewSchools Venture Fund, a venture philanthropy firm working to transform public education through powerful ideas and passionate entrepreneurs.  In 2007, Amy joined The Monitor Group as a consultant in San Francisco, where she remained until 2012.  At Monitor she focused on strategy and growth, in both the non-profit and commercial sector. Prior to HBS, she served as a teacher through Teach for America in Oakland, California as well as launched SCORES in the Bay Area.  Amy has a B.A. degree from Dartmouth College.


Mr. Andrea Marano is a co-founder and CEO of Fondo Italiano per l'Efficienza Energetica SGR S.p.A, the first equity fund dedicated to energy efficiency projects in Italy.  He is a the former CEO and shareholder of Lucos Alternative Energies, former executive of Enel Green Power, as well as a former assistant vice president at The Capital Group Companies in London. Andrea holds an MBA from the Harvard Business School and a B.A. in Finance and Economics from Bocconi University in Milan.  Andrea has been a Chartered Financial Analyst®  Charterholder since 2002.


Ms. Sara Shnider is Sr. Manager, Academic Affairs and Networks at Teva Pharmaceuticals.  Prior to Teva, she served as Executive Director of Prize4Life from 2014 to 2016.  Prior to Prize4Life, Sara was a senior industry contracts officer in the Office of Innovation, Technology and Alliances at the University of California, San Francisco (UCSF) and a Mirzayan Science and Technology Policy Fellow at the National Academy of Sciences in Washington, D.C.  Sara earned her Ph.D. in the laboratory of Dr. Jeffrey Macklis in the department of Molecular and Cellular Biology at Harvard University. While in graduate school, Sara served as a scientific advisor for Prize4Life during the founding stages of the organization. Sara earned a B.Sc. in Biology with honors from Hebrew University in Jerusalem, and an M.Sc. in bioinformatics from the Weizmann Institute of Science.


Dr. Nicole Szlezák, Chair of the Board, is a partner at McKinsey & Company, where she has served clients within the healthcare and pharmaceuticals practice since 2008. Prior to joining McKinsey, Nicole was a research fellow in the Sustainability Science Program at Harvard University, where she worked on global health governance and international health and science policy. During her time at Harvard, Nicole joined Prize4Life and served as the Chief Scientific Officer from 2006 through 2007.  Before coming to Harvard, Nicole was a clinical researcher at the Institute of Tropical Medicine at the University of Tuebingen, Germany, where her work focused on malaria and schistosomiasis in sub-Saharan Africa. Nicole holds an M.D. from Humboldt University in Berlin, and an M.P.A. and Ph.D. in Public Policy from Harvard University.


Mr. Guy Yamen is a Managing Partner at TPY Capital. He is a former business analyst/engagement manager for McKinsey & Company, as well as a summer associate with Lehman Brothers and a summer analyst with Goldman Sachs. He is also a former financial reporter for the Marker Media. Guy holds an MBA with distinction from the Harvard Business School and an LL.B. (Law degree) and a B.A. in Economics from Tel Aviv University in Israel.